Free Trial

IQVIA (IQV) Competitors

IQVIA logo
$157.71 -2.42 (-1.51%)
Closing price 07/15/2025 03:59 PM Eastern
Extended Trading
$157.74 +0.03 (+0.02%)
As of 07/15/2025 07:20 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

IQV vs. BRKR, ICLR, MEDP, TECH, A, CRL, DHR, MTD, TMO, and WAT

Should you be buying IQVIA stock or one of its competitors? The main competitors of IQVIA include Bruker (BRKR), Icon (ICLR), Medpace (MEDP), Bio-Techne (TECH), Agilent Technologies (A), Charles River Laboratories International (CRL), Danaher (DHR), Mettler-Toledo International (MTD), Thermo Fisher Scientific (TMO), and Waters (WAT).

IQVIA vs. Its Competitors

IQVIA (NYSE:IQV) and Bruker (NASDAQ:BRKR) are related companies, but which is the superior investment? We will compare the two businesses based on the strength of their media sentiment, valuation, risk, analyst recommendations, dividends, earnings, profitability and institutional ownership.

IQVIA currently has a consensus price target of $222.45, suggesting a potential upside of 41.05%. Bruker has a consensus price target of $52.89, suggesting a potential upside of 26.05%. Given IQVIA's stronger consensus rating and higher probable upside, research analysts plainly believe IQVIA is more favorable than Bruker.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
IQVIA
0 Sell rating(s)
7 Hold rating(s)
16 Buy rating(s)
1 Strong Buy rating(s)
2.75
Bruker
0 Sell rating(s)
6 Hold rating(s)
4 Buy rating(s)
0 Strong Buy rating(s)
2.40

89.6% of IQVIA shares are held by institutional investors. Comparatively, 79.5% of Bruker shares are held by institutional investors. 1.6% of IQVIA shares are held by insiders. Comparatively, 27.3% of Bruker shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term.

IQVIA has higher revenue and earnings than Bruker. IQVIA is trading at a lower price-to-earnings ratio than Bruker, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
IQVIA$15.41B1.77$1.37B$7.3421.49
Bruker$3.45B1.85$113.10M$0.5280.69

IQVIA has a beta of 1.3, meaning that its share price is 30% more volatile than the S&P 500. Comparatively, Bruker has a beta of 1.18, meaning that its share price is 18% more volatile than the S&P 500.

In the previous week, IQVIA had 16 more articles in the media than Bruker. MarketBeat recorded 23 mentions for IQVIA and 7 mentions for Bruker. Bruker's average media sentiment score of 1.16 beat IQVIA's score of 0.98 indicating that Bruker is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
IQVIA
13 Very Positive mention(s)
0 Positive mention(s)
5 Neutral mention(s)
1 Negative mention(s)
0 Very Negative mention(s)
Positive
Bruker
4 Very Positive mention(s)
0 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

IQVIA has a net margin of 8.61% compared to Bruker's net margin of 2.31%. IQVIA's return on equity of 29.16% beat Bruker's return on equity.

Company Net Margins Return on Equity Return on Assets
IQVIA8.61% 29.16% 6.96%
Bruker 2.31%19.47%5.95%

Summary

IQVIA beats Bruker on 13 of the 17 factors compared between the two stocks.

Get IQVIA News Delivered to You Automatically

Sign up to receive the latest news and ratings for IQV and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding IQV and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

IQV vs. The Competition

MetricIQVIAMED INSTRUMENTS IndustryMedical SectorNYSE Exchange
Market Cap$27.70B$6.83B$5.62B$20.84B
Dividend YieldN/A1.28%4.25%3.65%
P/E Ratio21.4925.9728.5727.17
Price / Sales1.7761.62423.3548.17
Price / Cash9.6420.3636.0222.28
Price / Book4.724.638.134.56
Net Income$1.37B$174.76M$3.24B$995.22M
7 Day Performance-2.73%-3.25%0.16%-1.16%
1 Month Performance-1.00%-0.33%5.95%3.18%
1 Year Performance-32.30%0.36%26.09%6.83%

IQVIA Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
IQV
IQVIA
4.9182 of 5 stars
$157.71
-1.5%
$222.45
+41.1%
-30.2%$27.70B$15.41B21.4988,000Upcoming Earnings
BRKR
Bruker
4.9782 of 5 stars
$41.27
-2.8%
$52.89
+28.2%
-33.8%$6.25B$3.37B79.3711,396Positive News
High Trading Volume
ICLR
Icon
4.4303 of 5 stars
$147.59
-1.7%
$213.08
+44.4%
-57.3%$11.92B$8.19B16.0841,900Upcoming Earnings
MEDP
Medpace
4.233 of 5 stars
$318.90
-0.8%
$344.82
+8.1%
-29.6%$9.17B$2.11B24.345,900Upcoming Earnings
TECH
Bio-Techne
4.8693 of 5 stars
$51.53
-3.0%
$72.00
+39.7%
-33.4%$8.08B$1.16B62.843,100
A
Agilent Technologies
4.7718 of 5 stars
$119.21
-1.8%
$140.92
+18.2%
-13.6%$33.86B$6.51B29.4317,900
CRL
Charles River Laboratories International
4.8115 of 5 stars
$153.93
-2.0%
$171.85
+11.6%
-28.6%$7.56B$4.05B-236.8220,100Positive News
DHR
Danaher
4.97 of 5 stars
$199.60
-1.8%
$248.61
+24.6%
-21.7%$142.85B$23.88B38.7663,000Positive News
Upcoming Earnings
MTD
Mettler-Toledo International
3.9716 of 5 stars
$1,188.28
-1.7%
$1,300.36
+9.4%
-14.2%$24.69B$3.87B29.6317,300Positive News
TMO
Thermo Fisher Scientific
4.991 of 5 stars
$418.76
-2.5%
$604.05
+44.2%
-23.1%$158.08B$42.88B24.56125,000Positive News
Upcoming Earnings
Dividend Announcement
WAT
Waters
4.8761 of 5 stars
$346.35
-1.1%
$388.00
+12.0%
-4.3%$20.61B$2.96B31.437,600Trending News
Analyst Forecast

Related Companies and Tools


This page (NYSE:IQV) was last updated on 7/16/2025 by MarketBeat.com Staff
From Our Partners